Carbon ion radiotherapy in a hypofractionation regimen for stage I non-small-cell lung cancer
Introduction: In 1994, we started carbon-ion radiotherapy (CIRT) for peripheral stage I non-small-cell lung cancer (NSCLC). First, two phase I/II clinical trials demonstrated the optimal doses of 90.0 GyE in 18 fractions over 6 weeks (Protocol 9303) and 72.0 GyE in 9 fractions over 3 weeks (Protocol...
Main Authors: | Takahashi, Wataru, Nakajima, Mio, Yamamoto, Naoyoshi, Tsuji, Hiroshi, Kamada, Tadashi, Tsujii, Hirohiko |
---|---|
Format: | Online |
Language: | English |
Published: |
Oxford University Press
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3941516/ |
Similar Items
-
Carbon Ion Radiotherapy for Oligo-Recurrence in the Lung
by: Yamamoto, Naoyoshi, et al.
Published: (2013) -
Carbon ion radiotherapy for oligo-recurrent lung metastases from colorectal cancer: a feasibility study
by: Takahashi, Wataru, et al.
Published: (2014) -
Up-to-date results of carbon-ion radiotherapy for prostate cancer
by: Nomiya, Takuma, et al.
Published: (2014) -
A Review of Update Clinical Results of Carbon Ion Radiotherapy
by: Tsujii, Hirohiko, et al.
Published: (2012) -
Prognostic analysis of radiation pneumonitis: carbon-ion radiotherapy in patients with locally advanced lung cancer
by: Kazuhiko Hayashi, et al.
Published: (2017-05-01)